高级检索
当前位置: 首页 > 详情页

Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Orthoped, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 3, Dept Orthoped, 139 Zigiang Rd, Shijiazhuang 050051, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Canc Res Inst, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China [4]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China
出处:
ISSN:

关键词: Osteosarcoma Radioresistance Hypoxia Autophagy HIF-1 alpha LC3

摘要:
Osteosarcoma (OS) responds poorly to radiotherapy, but the mechanism is unclear. We found OS tumor tissues expressed high level of protein HIF-1 alpha, a common biological marker indicative of hypoxia. It is known that hypoxic cells are generally radioresistant because of reduced production of irradiation-induced DNA-damaging reactive oxygen species (ROS) in the anaerobic condition. Here we report another mechanism how hypoxia induces radioresistance. In MG-63 human osteosarcoma cells, hypoxic pretreatment increased the cellular survival in irradiation. These hypoxia-exposed cells displayed compartmental recruitment of GFP-tagged LC3 and expression of protein LC3-II, and restored the radio sensitivity upon autophagy inhibition. The following immunohistochemistry of OS tumor tissue sections revealed upregulated LC3 expression in a correlation with HIF-1 alpha protein level, implying the possibly causative link between hypoxia and autophagy. Further studies in MG-63 cells demonstrated hypoxic pretreatment reduced cellular and mitochondrial ROS production during irradiation, while inhibition of autophagy re-elicited them. Taken together, our study suggests hypoxia can confer cells resistance to irradiation through activated autophagy to accelerate the clearance of cellular ROS products. This might exist in human osteosarcoma as an additional mechanism for radioresistance. (C) 2016 The Authors. Published by Elsevier GmbH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Orthoped, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构: [2]Hebei Med Univ, Hosp 3, Dept Orthoped, 139 Zigiang Rd, Shijiazhuang 050051, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号